Xiaoli Shen

981 total citations
48 papers, 611 citations indexed

About

Xiaoli Shen is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoli Shen has authored 48 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoli Shen's work include Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (6 papers) and Glioma Diagnosis and Treatment (5 papers). Xiaoli Shen is often cited by papers focused on Ferroptosis and cancer prognosis (6 papers), Cancer-related molecular mechanisms research (6 papers) and Glioma Diagnosis and Treatment (5 papers). Xiaoli Shen collaborates with scholars based in China, United States and Belgium. Xiaoli Shen's co-authors include Huaizhen Liang, Tingting Zhou, Yun Tao, Surong Mei, Miriam Falzon, Yaqian Feng, Dan Luo, Rianka P. M. Vloet, R.J.M. Moormann and Jeroen Kortekaas and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaoli Shen

44 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoli Shen China 15 176 104 83 77 72 48 611
Yu-Chun Lin Taiwan 18 347 2.0× 90 0.9× 97 1.2× 65 0.8× 29 0.4× 32 1.1k
J. Grosjean France 15 328 1.9× 159 1.5× 95 1.1× 98 1.3× 49 0.7× 20 762
Yutaka Okamoto Japan 18 144 0.8× 27 0.3× 96 1.2× 130 1.7× 112 1.6× 79 906
Bo Dong China 15 255 1.4× 103 1.0× 39 0.5× 149 1.9× 60 0.8× 82 792
Xiaorui Wang China 17 235 1.3× 36 0.3× 60 0.7× 44 0.6× 69 1.0× 79 766
Junbin Huang China 15 185 1.1× 40 0.4× 43 0.5× 45 0.6× 14 0.2× 73 617
Qi Xiao China 18 323 1.8× 136 1.3× 61 0.7× 57 0.7× 49 0.7× 59 759
Hiroshi Harada Japan 16 228 1.3× 80 0.8× 47 0.6× 71 0.9× 16 0.2× 82 741
Yingxian Liu China 18 145 0.8× 58 0.6× 96 1.2× 112 1.5× 29 0.4× 82 799
Xiaolin Xu China 23 275 1.6× 130 1.3× 245 3.0× 82 1.1× 156 2.2× 101 1.6k

Countries citing papers authored by Xiaoli Shen

Since Specialization
Citations

This map shows the geographic impact of Xiaoli Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Shen more than expected).

Fields of papers citing papers by Xiaoli Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Shen. The network helps show where Xiaoli Shen may publish in the future.

Co-authorship network of co-authors of Xiaoli Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Shen. A scholar is included among the top collaborators of Xiaoli Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Shen. Xiaoli Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vandeginste, Veerle, Junjian Zhang, Shangbin Chen, et al.. (2025). Control mechanism of pressure drop rate on coalbed methane productivity by using production data and physical simulation technology. Fuel. 406. 137060–137060.
2.
3.
Zhang, Qing, et al.. (2024). Current trends and advancements in utilizing endoscopic cyclophotocoagulation for the Treatment of Glaucoma. Lasers in Medical Science. 39(1). 277–277.
4.
Zhang, Zhe, Xiaoli Shen, Zilong Tan, et al.. (2023). Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis. Frontiers in Genetics. 13. 1053263–1053263. 12 indexed citations
5.
Gong, Di, et al.. (2023). Development and evaluation of a risk prediction model for diabetes mellitus type 2 patients with vision-threatening diabetic retinopathy. Frontiers in Endocrinology. 14. 1244601–1244601. 9 indexed citations
6.
Tan, Zilong, Zhe Zhang, Kai Yu, et al.. (2022). Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma. Frontiers in Neurology. 13. 964590–964590. 4 indexed citations
7.
Xiao, Bing, Yanghua Fan, Zhe Zhang, et al.. (2021). Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma. Frontiers in Oncology. 11. 625220–625220. 14 indexed citations
8.
Yu, Kai, Huan Yang, Qiao‐Li Lv, et al.. (2021). Construction of a competitive endogenous RNA network and analysis of potential regulatory axis targets in glioblastoma. Cancer Cell International. 21(1). 102–102. 8 indexed citations
9.
Wang, Dapeng, et al.. (2021). Microsurgical resection of trigone ventricular meningiomas using the parieto-occipital approach: a retrospective analysis of 47 cases and literature review. Journal of Neurosurgical Sciences. 65(5). 518–523. 1 indexed citations
10.
Liang, Huaizhen & Xiaoli Shen. (2020). LXR activation radiosensitizes non-small cell lung cancer by restricting myeloid-derived suppressor cells. Biochemical and Biophysical Research Communications. 528(2). 330–335. 32 indexed citations
11.
He, Wei, Ling Huang, Xiaoli Shen, et al.. (2016). Relationship between RSUME and HIF-1α/VEGF-A with invasion of pituitary adenoma. Gene. 603. 54–60. 23 indexed citations
12.
Cheng, Shiqi, Xin Xu, Weiwei Gao, et al.. (2016). Over-expression of LRIG1 suppresses biological function of pituitary adenoma via attenuation of PI3K/AKT and Ras/Raf/ERK pathways in vivo and in vitro. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(4). 558–563. 7 indexed citations
13.
Kortekaas, Jeroen, Rianka P. M. Vloet, Alexander J. McAuley, et al.. (2015). Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice. Vector-Borne and Zoonotic Diseases. 15(12). 759–764. 69 indexed citations
14.
Zhang, Yan, et al.. (2014). Hedyotis diffusa Willd extract inhibits the growth of human glioblastoma cells by inducing mitochondrial apoptosis via AKT/ERK pathways. Journal of Ethnopharmacology. 158. 404–411. 21 indexed citations
16.
Shen, Xiaoli. (2010). The expression change of notch signal pathway in hippocampus after traumatic brain injury in mice. 1 indexed citations
17.
Shen, Xiaoli, et al.. (2007). PTHrP contributes to the anti-proliferative and integrin α6β4-regulating effects of 1,25-dihydroxyvitamin D3. Steroids. 72(14). 930–938. 8 indexed citations
18.
Shen, Xiaoli, Piotr Rychahou, B. Mark Evers, & Miriam Falzon. (2007). PTHrP increases xenograft growth and promotes integrin α6β4 expression and Akt activation in colon cancer. Cancer Letters. 258(2). 241–252. 20 indexed citations
19.
König, Rolf, Xiaoli Shen, Rosario Maroto, & Timothy L. Denning. (2002). The Role of CD4 in Regulating Homeostasis of T Helper Cells. Immunologic Research. 25(2). 115–130. 13 indexed citations
20.
Shen, Xiaoli. (1998). Regulation of T cell immunity and tolerance in vivo by CD4. International Immunology. 10(3). 247–257. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026